Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Experts believe volatility is here to stay for some time, at least till China stabilises and clarity regarding the US Fed's interest rate move emerges.
Experts suggest domestic factors rather than the Greece crisis would determine the course of the Indian equities.
Natco Pharma, Wockhardt and Marksans have rallied between 50 and 70 per cent in the year till date.
FIIs are looking at the long-term story and initiatives of Indian pharma companies to transform themselves into global entities.
US Fed rate rise raises risk of further drying up of FII flows.
.jpg)
Inflows cross $10-billion mark for 3rd consecutive year.
'Cognizant's results indicate that digital related spends can more than offset headwinds in traditional services'
Raghavendra Kamath reports on what ails India's real estate sector.
According to Rahul Rege, business head (retail) at Emkay Global Financial Services, it is difficult to track more than 10 stocks.
Licence winners are expected to be announced by the first quarter of 2014.
Broader markets underperformed the benchmark indices with BSE Midcap and Smallcap indces slipping 0.8%-1.1%
Once tipped to emerge as the biggest exporter, the pharmaceutical industry is yet to acquire the scale of those in software services, says Krishna Kant.
Sensex closed 63.82 points higher at 26,851.05 in Muhurat trading; Nifty rises 18.65 points to end at 8,014.55.
Ajit Mishra, vice president, Research, Religare Broking, answers readers' queries on stocks they own or want to buy.
Nifty, which has struggled around 8550-8560 levels managed to blast past this resistance and close above the psychological mark of 8600.
Cashi Crisis: Day 9: Aaj ki Taaza Khabar!
Most experts said indices would open higher on Monday and rally might sustain for a few sessions
